Show Impressions
Estimates only, not verified by show
Est. Podcast Downloads
4,040
Unlock show and brand data, including top ads, overall spend, and the ability to listen to ads.
Direct Response
Brands with CTAs
62%
Host Read %
% of host read ads
46%
Unlock show and brand data, including top ads, overall spend, and the ability to listen to ads.
The Bottom Line
This show has an estimated 4K audience size, runs 46% host read ads and promotes 62% of ads for direct response advertisers.
| Advertisers | Week2/23 | Week3/2 | Week3/9 | Week3/16 | Week3/23 | Week3/30 | Week4/6 | Week4/13 | Week4/20 | Week4/27 | Week5/4 | Week5/11 | Week5/18 | Week5/25 | Week6/1 | Week6/8 | Week6/15 | Week6/22 | Week6/29 | Week7/6 | Week7/13 | Week7/20 | Week7/27 | Week8/3 | Week8/10 | Week8/17 | Week8/24 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 AstraZenecaastrazeneca.com | AstraZeneca | 1 | Test run 0% |
Fans by country:
Unlock show and brand data, including top ads, overall spend, and the ability to listen to ads.
Top Spenders | Est. Spent | Change | Host Read % | DR % | # of ads | Frequency | Top Shows |
|---|---|---|---|---|---|---|---|
Naterra | $182 | 0.0% | 0% | 100% | 4.0ad units | Core Performer |  +1 |
Oncology Nursing Society | $131 | 0.0% | 33% | 100% | 3.0ad units | Test run | |
AstraZeneca pharmaceuticals | $126 | 0.0% | 100% | 0% | 2.0ad units | Test run |   +1 |
Unlock show and brand data, including top ads, overall spend, and the ability to listen to ads.
Episode 406: Drug Resistance Biomarkers and Their Impact on Cancer Treatment Choices
0:00 / 0:17#1
Run on 1x episodeUnlock show and brand data, including top ads, overall spend, and the ability to listen to ads.